Canada markets close in 2 hours 12 minutes

IMV Inc. (IMV.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
6.28+0.01 (+0.16%)
As of 1:45PM EDT. Market open.
Full screen
Previous Close6.27
Open6.22
Bid6.27 x 0
Ask6.31 x 0
Day's Range6.10 - 6.42
52 Week Range1.98 - 9.25
Volume122,456
Avg. Volume379,512
Market Cap417.505M
Beta (5Y Monthly)2.15
PE Ratio (TTM)N/A
EPS (TTM)-0.64
Earnings DateAug. 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.05
  • Business Wire

    IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum

    IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccine against infectious diseases, today announced that company’s Chief Executive Officer, Frederic Ors will participate at the Vaccines Panel of the 20th Annual Biotech in Europe Forum held on September 21-24, 2020.

  • ACCESSWIRE

    LD Micro 360 Companies: --Set to Present this Week.

    LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

  • Business Wire

    IMV to Participate at Four Upcoming Investor Conferences

    IMV Inc. ("IMV" or the "Corporation") (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced that the IMV’s executive management team will participate at four upcoming virtual investor conferences in September: